Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)

NCT06655337 | Recruiting

• 1 other identifier: AAUEffidux
• Study Type: interventional
• Target: 417
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to evaluate whether the use of the medidux™ smartphone app can optimize post-discharge management for patients admitted to Acute Admission Units (AAU) with non-urgent health complaints. This trial includes adult patients (age ≥ 18) in Emergency Severity Index (ESI) triage system groups 4 (standard) or 5 (non-urgent), presenting with primary symptoms such as cough, back pain, or abdominal discomfort. The main question it aims to answer is: Can the medidux™ app reduce the incidence of AAU readmissions, emergency hospitalizations, or consultations with other medical providers within 7 days after initial admission? Researchers will compare participants using the medidux™ app (intervention arm) with those receiving standard care (control arm) to observe potential differences in the rates of readmissions, emergency hospitalizations, and medical consultations. Participants will:

• use the medidux™ app to monitor their symptoms and vital parameters for 7 days after discharge (intervention arm).
• receive follow-up consultations at day 7 and at day 28 to assess symptom progression and any healthcare interactions (both arms).

Conditions

Acute Disease; Acute Hospitalization; Coughing; Back Pain; Abdominal Pain (AP); Patient Discharge; Patient Readmission; Mobile Health Apps; Mobile Health Technology (mHealth); Patient Reported Outcome (PRO)

Keywords

Acute Disease; Patient Discharge; Patient Readmission; Coughing; Back Pain; Abdominal Pain; Mobile Health Applications; Remote Monitoring; Post-discharge Care; Symptom Monitoring; Health Behaviour; Telemedicine; Randomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

• Incidence of AAU Readmissions, Emergency Hospitalizations, and Consultations of Other Medical Providers within 7 (± 1) days

  This measure evaluates the number of participants who experience at least one AAU readmission, emergency hospitalization, or consultation with other medical providers within 7 days of the initial AAU admission. This is a binary measure (yes/no) indicating whether such an event has occurred.

  7 (± 1) days after the initial AAU admission

Secondary Outcomes (12)

• Incidence of AAU Readmissions, Emergency Hospitalizations, and Consultations of Other Medical Providers within 28 (± 1) days.

  28 (± 1) days after the initial AAU admission

• Incidence of AAU Readmissions within 7 (± 1) days

  7 (± 1) days after the initial AAU admission

• Incidence of AAU Readmissions within 28 (± 1) days

  28 (± 1) days after the initial AAU admission

• Incidence of Emergency Hospitalizations within 7 (± 1) days

  7 (± 1) days after the initial AAU admission

• Incidence of Emergency Hospitalizations within 28 (± 1) days

  28 (± 1) days after the initial AAU admission

Study Arms (2)

Intervention Arm: medidux App

EXPERIMENTAL

Participants in this arm will use the medidux™ smartphone application to monitor their symptoms and vital signs for 7 days following discharge from the Acute Admission Unit (AAU). The app provides health monitoring features, prompts for symptom tracking, and guidance on whether further medical consultation is required. Participants will log daily health data and receive automated reminders. The app aims to reduce post-discharge readmissions and emergency hospitalizations by providing real-time support. Follow-up assessments will be conducted at day 7 and day 28 post-discharge to evaluate symptom progression and healthcare utilization.

Device: Smartphone Application for Post-Discharge Symptom Monitoring

Control Arm: Standard Post-Discharge Care

NO INTERVENTION

Participants in this arm will receive standard post-discharge care as currently practiced in the Acute Admission Unit (AAU). This may include follow-up calls or appointments with healthcare providers to monitor symptoms and progression after discharge, but participants will not use the medidux™ app for symptom tracking or monitoring. Follow-up assessments will be conducted at day 7 and day 28 post-discharge to evaluate symptom progression and healthcare utilization.

Interventions

Smartphone Application for Post-Discharge Symptom Monitoring DEVICE

This intervention involves the use of a smartphone application designed for symptom monitoring. The app enables participants to log daily health data, including symptoms and vital signs, for 7 days following discharge. It provides automated prompts and guidance for self-management, including when to seek medical assistance. The app does not provide direct medical intervention but facilitates remote symptom tracking to reduce readmissions and emergency hospitalizations. Follow-up consultations are conducted at day 7 and day 28.

Intervention Arm: medidux App

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Signed Informed Consent Form (ICF)
• Age ≥ 18 years
• (Self-)admission to the involved Acute Admissions Unit (AAU)
• "Lead symptom" identified as coughing, back pain or abdominal discomfort
• Participant within ESI triage system group 4 (standard) and 5 (non-urgent)
• German-speaking
• Ownership of a smartphone or other mobile device with iOS or Android operating system

You may not qualify if:

• Age \< 18 years
• Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted
• Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system
• Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial

Sponsors & Collaborators

• Mobile Health AG: lead
• Palleos Healthcare GmbH: collaborator

Study Sites (1)

Notfallzentrum See-Spital Horgen

Horgen, Canton of Zurich, 8810, Switzerland

RECRUITING

MeSH Terms

Conditions

Acute Disease; Cough; Back Pain; Abdominal Pain

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Respiration Disorders; Respiratory Tract Diseases; Signs and Symptoms, Respiratory; Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms, Digestive

Central Study Contacts

Andreas Trojan, MD

CONTACT

+41763430200; andreas.trojan@mobilehealth.ch

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 21, 2024
• First Posted: October 23, 2024
• Study Start: September 28, 2025
• Primary Completion (Estimated): March 28, 2027
• Study Completion (Estimated): March 28, 2027
• Last Updated: October 3, 2025

Record last verified: 2025-09

Locations

CH (1)